Virtus ETF Advisers’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Virtus ETF Advisers's CLBT Position: Q1 2026 in Review
Virtus ETF Advisers sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 12,954 shares — an estimated $234K sold.
Virtus ETF Advisers first reported a position in CLBT in Q1 2025 and held it in 4 quarters. The position peaked at $252K in Q1 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.
- Virtus ETF Advisers reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
- Virtus ETF Advisers sold 12,954 Cellebrite shares in Q1 2026, an estimated $234K.
- Virtus ETF Advisers first reported a position in Cellebrite in Q1 2025 and held it in 4 quarters.
- Virtus ETF Advisers's Cellebrite position peaked at $252K in Q1 2025.
- 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.
Based on Virtus ETF Advisers's 13F filing for Q1 2026, filed 14 May 2026.